Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-011730
Filing Date
2021-03-15
Accepted
2021-03-15 20:44:43
Documents
2
Period of Report
2021-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3908
2 EX-24 DOCUMENT attachment1.htm EX-24 3986
  Complete submission text file 0000899243-21-011730.txt   9483
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Issuer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103
Business Address
Harwin Peter Evan (Reporting) CIK: 0001663607 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38443 | Film No.: 21743292